We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Allergan IP Deal With Tribe Could Have Big Impact On PTAB

Law360, New York (September 15, 2017, 7:35 PM EDT) -- Allergan PLC's attempt to use a Native American tribe’s sovereign immunity to shield patents for its best-selling eye drug from inter partes review raises new questions for the Patent Trial and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.